On August 30, 2024, Innovent Bio announced that under the terms of the 2024 share plan, it has granted 170,600 share options to 6 non-related employees and 683,400 restricted shares to 16 non-related employees. The exercise price of the share options is HKD 43.77 per share, with a maximum exercise period of 10 years. The share options and restricted shares will respectively vest in 2027 and 2028 and are subject to individual annual performance targets. This initiative aims to provide compensation, incentives, and retention rewards, and encourages employees to contribute to the long-term development of the company. The granting of share options and restricted shares does not require shareholder approval and will not result in a dilution of more than 1% of the issued shares.

On August 30, 2024, Innovent Bio announced that under the terms of the 2024 share plan, it has granted 170,600 share options to 6 non-related employees and 683,400 restricted shares to 16 non-related employees. The exercise price of the share options is HKD 43.77 per share, with a maximum exercise period of 10 years. The share options and restricted shares will respectively vest in 2027 and 2028 and are subject to individual annual performance targets. This initiative aims to provide compensation, incentives, and retention rewards, and encourages employees to contribute to the long-term development of the company. The granting of share options and restricted shares does not require shareholder approval and will not result in a dilution of more than 1% of the issued shares.